arrow
C

Christi J. van Asperen

leiden university medical center
H指数:63
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density

围绝经期风险降低性输卵管卵巢切除术的长期对骨密度的影响

2025-10-040
OA
Capturing breast cancers’ copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond

在常规病理学中捕获乳腺癌的拷贝数景观:利用低分辨率、全基因组测序来识别同源重组缺陷(HRD)及其相关特征

2025-08-230
PRE
Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers
2024-06-041
OAAI
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction

在基于canrik的乳腺癌风险预测中纳入遗传和非遗传危险因素的临床意义

BREAST
IF7.9
2024-02-014
OAAI
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
2023-06-275
OAAI
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy
2023-04-012
OAAI
Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program
2023-03-010
PRE
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study
2023-02-194
OA
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases
2022-09-2220
OA
Universal Immunohistochemistry for Lynch Syndrome: A Systematic Review and Meta-analysis of 58,580 Colorectal Carcinomas

Lynch综合征的通用免疫组织化学: 58,580例结直肠癌的系统评价和荟萃分析

2022-03-0120
OAAI
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study

化疗对BRCA1和BRCA2突变携带者对侧乳腺癌风险的影响: 一项全国性队列研究

BREAST
IF7.9
2022-02-018
OAAI
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

携带BRCA1和BRCA2致病错义变异体的女性与携带蛋白截断变异体的女性相比,患乳腺癌和卵巢癌的风险

2022-01-0117
OAAI
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
2021-07-266
OAAI
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
2021-03-1251
OAAI